Search Results - "Burden, David A"
-
1
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Published in The New England journal of medicine (07-03-2019)“…Seven patients with pustular psoriasis, three with mutations in IL36RN , were treated with a monoclonal antibody against interleukin-36 receptor and had…”
Get full text
Journal Article -
2
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Published in Journal of investigative dermatology (01-11-2015)“…Drug survival reflects a drug’s effectiveness, safety, and tolerability. We assessed the drug survival of biologics used to treat psoriasis in a prospective…”
Get full text
Journal Article -
3
Response to: Letter to Editor Regarding “Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study”
Published in Dermatology and therapy (01-04-2024)Get full text
Journal Article -
4
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR
Published in JAMA dermatology (Chicago, Ill.) (01-05-2018)“…Patients with psoriasis enrolled in clinical trials of biologics may not be representative of the real-world population. There is evidence that patients…”
Get more information
Journal Article -
5
Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
Published in American journal of human genetics (09-09-2011)“…Generalized pustular psoriasis (GPP) is a rare and yet potentially lethal clinical variant of psoriasis, characterized by the formation of sterile cutaneous…”
Get full text
Journal Article -
6
Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional Pathways
Published in Journal of investigative dermatology (01-03-2012)“…Driven by advances in molecular genetic technologies and statistical analysis methodologies, there have been huge strides taken in dissecting the complex…”
Get full text
Journal Article -
7
Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis
Published in Journal of allergy and clinical immunology (01-10-2022)“…Palmoplantar pustulosis (PPP) is a severe inflammatory skin disorder characterized by eruptions of painful, neutrophil-filled pustules on the palms and soles…”
Get full text
Journal Article -
8
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare
Published in BMJ open (30-03-2021)“…IntroductionGeneralized pustular psoriasis (GPP) is a rare, potentially life-threatening disease characterised by recurrent flares of widespread neutrophilic…”
Get full text
Journal Article -
9
AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking
Published in American journal of human genetics (01-05-2014)“…Adaptor protein complex 1 (AP-1) is an evolutionary conserved heterotetramer that promotes vesicular trafficking between the trans-Golgi network and the…”
Get full text
Journal Article -
10
Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris
Published in Journal of investigative dermatology (01-12-2015)“…Caspase recruitment family member 14 (CARD14, also known as CARMA2), is a scaffold protein that mediates NF-κB signal transduction in skin keratinocytes…”
Get full text
Journal Article -
11
Rare Pathogenic Variants in IL36RN Underlie a Spectrum of Psoriasis-Associated Pustular Phenotypes
Published in Journal of investigative dermatology (01-05-2013)Get full text
Journal Article -
12
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023: a pragmatic update
Published in British journal of dermatology (1951) (23-01-2024)“…The article provides a pragmatic update of the British Association of Dermatologists guidelines for biologic therapy for psoriasis…”
Get full text
Journal Article -
13
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis
Published in JAMA dermatology (Chicago, Ill.) (01-11-2020)“…Although palmoplantar pustulosis (PPP) can significantly impact quality of life, the factors underlying disease severity have not been studied. To examine the…”
Get more information
Journal Article -
14
Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene
Published in Human molecular genetics (01-07-2008)“…Psoriasis is an immune-mediated skin disorder that is inherited as a multifactorial trait. Linkage studies have clearly identified a primary disease…”
Get full text
Journal Article -
15
Dysregulation of Connexin Expression Plays a Pivotal Role in Psoriasis
Published in International journal of molecular sciences (04-06-2021)“…Background: Psoriasis, a chronic inflammatory disease affecting 2–3% of the population, is characterised by epidermal hyperplasia, a sustained pro-inflammatory…”
Get full text
Journal Article -
16
Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis
Published in Human genetics (01-09-2007)“…Psoriasis is an inflammatory skin disorder that is inherited as a multifactorial trait. Genetic analyses have repeatedly identified a primary disease…”
Get full text
Journal Article -
17
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
Published in Dermatology and therapy (01-10-2023)“…Introduction We evaluated the anti-interleukin-36 receptor antibody spesolimab in patients with moderate-to-severe palmoplantar pustulosis (PPP). Methods This…”
Get full text
Journal Article -
18
Loss of IL36RN Function Does Not Confer Susceptibility to Psoriasis Vulgaris
Published in Journal of investigative dermatology (01-01-2014)Get full text
Journal Article -
19
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation
Published in Radiology (01-09-2010)“…To determine the ability of different types of gadolinium-based contrast agents (GBCAs) to stimulate fibroblast proliferation in monolayer cell culture. The…”
Get full text
Journal Article -
20
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel
Published in Skin health and disease (01-06-2024)“…This article presents the results of the UK extension of a previously conducted global Delphi panel on generalised pustular psoriasis (GPP). Five UK based…”
Get full text
Journal Article